Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 10:102:e6.
doi: 10.1017/S0016672320000075.

Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?

Tu Nguyen-Dumont  1   2 , Pawel Karpinski  3 , Maria M Sasiadek  3 , Hayane Akopyan  4   5 , Jason A Steen  1 , Derrick Theys  1 , Fleur Hammet  1   2 , Helen Tsimiklis  1   2 , Daniel J Park  2   6 , Bernard J Pope  1   6   7 , Ryszard Slezak  3 , Agnieszka Stembalska  3 , Karolina Pesz  3 , Nataliya Kitsera  4 , Aleksandra Siekierzynska  8 , Melissa C Southey  1   2   9 , Aleksander Myszka  5
Affiliations

Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?

Tu Nguyen-Dumont et al. Genet Res (Camb). .

Abstract

Purpose: To characterize the spectrum of BRCA1 and BRCA2 pathogenic germline variants in women from south-west Poland and west Ukraine affected with breast or ovarian cancer. Testing in women at high risk of breast and ovarian cancer in these regions is currently mainly limited to founder mutations.

Methods: Unrelated women affected with breast and/or ovarian cancer from Poland (n = 337) and Ukraine (n = 123) were screened by targeted sequencing. Excluded from targeted sequencing were 34 Polish women who had previously been identified as carrying a founder mutation in BRCA1. No prior testing had been conducted among the Ukrainian women. Thus, this study screened BRCA1 and BRCA2 in the germline DNA of 426 women in total.

Results: We identified 31 and 18 women as carriers of pathogenic/likely pathogenic (P/LP) genetic variants in BRCA1 and BRCA2, respectively. We observed five BRCA1 and eight BRCA2 P/LP variants (13/337, 3.9%) in the Polish women. Combined with the 34/337 (10.1%) founder variants identified prior to this study, the overall P/LP variant frequency in the Polish women was thus 14% (47/337). Among the Ukrainian women, 16/123 (13%) women were identified as carrying a founder mutation and 20/123 (16.3%) were found to carry non-founder P/LP variants (10 in BRCA1 and 10 in BRCA2).

Conclusions: These results indicate that genetic testing in women at high risk of breast and ovarian cancer in Poland and Ukraine should not be limited to founder mutations. Extended testing will enhance risk stratification and management for these women and their families.

Keywords: BRCA1; BRCA2; breast cancer; founder mutations; genetic susceptibility; genetic testing; ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Berliner, J.L., Fay, A.M. & Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest Group (2007). Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling 16, 241–260. - PubMed
    1. Brozek, I., Cybulska, C., Ratajska, M. et al. (2011). Prevalence of the most frequent BRCA1 mutations in Polish population. Journal of Applied Genetics 52, 325–330. - PMC - PubMed
    1. Cybulski, C., Kluzniak, W., Huzarski, T. et al. (2019). The spectrum of mutations predisposing to familial breast cancer in Poland. International Journal of Cancer 145, 3311–3320. - PubMed
    1. Ellingford, J.M., Campbell, C., Barton, S. et al. (2017). Validation of copy number variation analysis for next-generation sequencing diagnostics. European Journal of Human Genetics 25, 719–724. - PMC - PubMed
    1. Gorski, B., Cybulski, C., Huzarski, T. et al. (2005). Breast cancer predisposing alleles in Poland. Breast Cancer Research and Treatment 92, 19–24. - PubMed

Publication types